Artal Group »

Korro Bio shares owned by Artal Group

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by Artal Group from 13F filings

Historical chart of Artal Group investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by Artal Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by Artal Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $20M 419k 47.93

More positions owned by Artal Group

Cava Group Ord (CAVA)
Scholar Rock Hldg Corp (SRRK)
Lexicon Pharmaceuticals Com New (LXRX)
Cytokinetics Com New (CYTK)
Apellis Pharmaceuticals (APLS)
Beigene Sponsored Adr (BGNE)
Kymera Therapeutics (KYMR)
Amicus Therapeutics (FOLD)
Morphic Hldg (MORF)
Springworks Therapeutics (SWTX)
Silence Therapeutics Ads (SLN)
Revolution Medicines (RVMD)
Argenx Se Sponsored Adr (ARGX)
Neumora Therapeutics (NMRA)
Arrowhead Pharmaceuticals (ARWR)

View all positions for Artal Group

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Eventide Asset Management
Citadel Advisors
Cormorant Asset Management
Artal Group
Qiming U.S. Ventures Management
72 Investment Holdings
Vanguard Group
Point72 Asset Management
Monashee Investment Management
Citigroup
Jane Street
Bank of America Corporation
North Star Investment Management

View all funds holding Korro Bio